These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2472166)

  • 1. Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).
    Dorey EL; Outram SV; Holder A; Rohatiner AZ; Cotter FE; Deane M; Stansfeld AG; Lister TA; Horton MA
    Br J Cancer; 1989 May; 59(5):772-4. PubMed ID: 2472166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of "non-specific" lymphoid infiltrates in bone marrow in high grade malignant peripheral non-Hodgkin's lymphomas].
    Budde R; Schaefer HE
    Verh Dtsch Ges Pathol; 1992; 76():136-9. PubMed ID: 1283244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease.
    Giles FJ; Vose JM; Do KA; Johnson MM; Manshouri T; Bociek G; Bierman PJ; O'Brien SM; Keating MJ; Kantarjian HM; Armitage JO; Albitar M
    Br J Haematol; 2003 Dec; 123(5):850-7. PubMed ID: 14632776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
    Salter DM; Krajewski AS; Cunningham S
    J Pathol; 1988 Mar; 154(3):209-22. PubMed ID: 3280770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
    Salter DM; Krajewski AS; Sheehan T; Turner G; Cuthbert RJ; Mclean A
    J Pathol; 1989 Nov; 159(3):211-20. PubMed ID: 2593045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
    Conlan MG; Bast M; Armitage JO; Weisenburger DD
    J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
    Kalyan K; Basu D; Soundararaghavan J
    Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
    Rowlands DC; Hansel TT; Crocker J
    J Pathol; 1990 Mar; 160(3):239-43. PubMed ID: 2139890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of clonal selection in a child with non-Hodgkin's lymphoma.
    Yumura-Yagi K; Fujinami A; Hara J; Ishihara S; Kawa-Ha K
    Cancer; 1989 Jun; 63(11):2130-3. PubMed ID: 2470488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.
    Armitage JO; Vose JM; Linder J; Weisenburger D; Harrington D; Casey J; Bierman P; Sorensen S; Hutchins M; Moravec DF
    J Clin Oncol; 1989 Dec; 7(12):1783-90. PubMed ID: 2585020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
    Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
    Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Virus and related changes in immunological parameters in non Hodgkin's lymphoma patients.
    el-Din HM; Attia MA; Hamza MR; Khaled HM; Thoraya MA; Eisa SA
    Egypt J Immunol; 2004; 11(1):55-64. PubMed ID: 15724387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in the expression of B-cell antigen in non-Hodgkin's lymphoma.
    Jones DB; Moore K; Wright DH
    Adv Exp Med Biol; 1988; 237():139-44. PubMed ID: 3075845
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reactivity of monoclonal antibodies LN-1 and LN-2 in non-Hodgkin's lymphoma].
    Ashiya M
    Rinsho Ketsueki; 1988 Dec; 29(12):2256-63. PubMed ID: 3266764
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromosome analysis of 30 cases of non-Hodgkin's lymphoma.
    Chenevix-Trench G; Brown JA; Tyler GB; Behm FG
    Med Oncol Tumor Pharmacother; 1988; 5(1):17-32. PubMed ID: 3259279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma.
    Martin P; Furman RR; Ruan J; Elstrom R; Barrientos J; Niesvizky R; Coleman M; Leonard JP
    Semin Hematol; 2008 Apr; 45(2):126-32. PubMed ID: 18381108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic analysis of 125 cases of non-Hodgkin's lymphoma.
    Liu L; Zhang M; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):547-50. PubMed ID: 18549626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.
    Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA
    Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.